Company Phoenix Life Sciences International Limited Other OTC
Equities
PLSI
US71910Q1022
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Janelle Marsden
CEO | Chief Executive Officer | - | - |
Lewis Humer
CHM | Chairman | 65 | 25/14/25 |
Stephen Cornford
CIO | Chief Investment Officer | - | - |
David Steinman
LAW | General Counsel | - | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Humer
CHM | Chairman | 65 | 25/14/25 |
Janelle Marsden
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,084,582 | 8,644,192 ( 85.72 %) | 0 | 85.72 % |
Company contact information
Phoenix Life Sciences International Ltd.
1810 East Sahara Avenue Suite 215
89139, Las Vegas
+
http://www.phoenixlife.coSector
1st Jan change | Capi. | |
---|---|---|
+40.73% | 74TCr | |
+32.83% | 60TCr | |
-6.30% | 35TCr | |
+15.15% | 32TCr | |
+4.05% | 28TCr | |
+15.00% | 24TCr | |
-5.52% | 21TCr | |
+6.17% | 16TCr | |
-0.45% | 16TCr |